Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
May 21 BMY Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
May 21 VIR Vir Biotechnology Announces SOLSTICE Data to be Featured as an Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2024
May 21 BMY 1 Stock I Wouldn't Touch With a 10-Foot Pole
May 21 BMY Bristol-Myers says FDA has revised decision date on injected Opdivo
May 21 BMY Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
May 20 INO Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)
May 20 GILD Gilead touts additional data on liver disease asset seladelpar ahead of PDUFA date
May 20 GILD Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch
May 20 NNVC Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
May 19 GILD Biopharma M&A surges year over year in Q1
May 18 GILD Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
May 18 BMY Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
May 17 BMY AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
May 17 BMY The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
May 17 GOVX GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
May 17 BMY Erasca restructures; Novartis moves to complete MorphoSys deal
May 17 BMY BMS reports four-year data from psoriasis treatment extension trial
May 16 BMY Walmart Earnings & the State of the Consumer
May 16 BMY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
May 16 BMY New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags